{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:08:31Z","timestamp":1792602511431,"version":"4.5.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>Transjugular intrahepatic portosystemic shunt (TIPS) reduces portal hypertension complications. Its impact on hepatocellular carcinoma (HCC) remains unclear. We evaluated 42,843 liver transplant candidates with HCC from the Scientific Registry of Transplant Recipients (2002\u20132022). 4,484 patients with and without TIPS were propensity score-matched 1:3. Analysing wait-list changes in total tumor volume, HCC count, and alpha-fetoprotein levels, and assessing survival from listing and transplantation; TIPS correlated with a decreased nodule count (\u22120.24 vs. 0.04, <jats:italic>p<\/jats:italic> = 0.028) over a median wait period of 284 days (IQR 195\u2013493) and better overall survival from listing (95.6% vs. 91.5% at 1\u00a0year, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001). It was not associated with changes in tumor volume (0.28 vs. 0.11\u00a0cm\u00b3\/month, <jats:italic>p<\/jats:italic> = 0.58) and AFP (14.37 vs. 20.67\u00a0ng\/mL, <jats:italic>p<\/jats:italic> = 0.42). Post-transplant survival rates (91.8% vs. 91.7% at 1\u00a0year, <jats:italic>p<\/jats:italic> = 0.25) and HCC recurrence (5.1% vs. 5.9% at 5 years, <jats:italic>p<\/jats:italic> = 0.14) were similar, with a median follow-up of 4.98 years (IQR 2.5\u20138.08). While TIPS was associated with a reduced nodule count and improved waitlist survival, it did not significantly impact HCC growth or aggressiveness. These findings suggest potential benefits of TIPS in HCC management, but further studies need to confirm TIPS safety.<\/jats:p>","DOI":"10.3389\/ti.2024.12781","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T06:52:57Z","timestamp":1719384777000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Transjugular Intrahepatic Portosystemic Shunt Is Associated With Better Waitlist Management of Liver Transplant Candidates With Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"37","author":[{"given":"Sofia","family":"El Hajji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Lacotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Moeckli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Compagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Toso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.jhepr.2020.100122","article-title":"Where Does TIPS Fit in the Management of Patients with Cirrhosis?","volume":"2","author":"Garc\u00eda-Pag\u00e1n","year":"2020","journal-title":"JHEPReport"},{"key":"B2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 Renewing Consensus in portal Hypertension","volume":"76","author":"Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2022.11.019","article-title":"Treatment of portal Hypertension in Patients with HCC in the Era of Baveno VII","volume":"78","author":"Thabut","year":"2023","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1111\/liv.14977","article-title":"Portal Hypertension and Hepatocellular Carcinoma: Des Liaisons Dangereuses","volume":"41","author":"Allaire","year":"2021","journal-title":"Liver Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/2050640617732886","article-title":"Is De Novo Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Increased?","volume":"6","author":"H\u00fcsing-Kabar","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.14218\/JCTH.2019.00007","article-title":"TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-Analysis","volume":"7","author":"Chen","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hep.20576","article-title":"Patients with Cirrhosis and Bare-Stent TIPS May Have Increased Risk of Hepatocellular Carcinoma","volume":"41","author":"Ba\u00f1ares","year":"2005","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/lt.26073","article-title":"Occult Hepatocellular Carcinoma Associated with Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients","volume":"27","author":"Krumeich","year":"2021","journal-title":"Liver Transplant : official Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/hep.510310122","article-title":"Hypoxic Stimulation of Vascular Endothelial Growth Factor Expression in Activated Rat Hepatic Stellate Cells","volume":"31","author":"Ankoma-Sey","year":"2000","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s00270-013-0698-8","article-title":"Efficacy of TACE in TIPS Patients: Comparison of Treatment Response to Chemoembolization for Hepatocellular Carcinoma in Patients with and without a Transjugular Intrahepatic Portosystemic Shunt","volume":"36","author":"Kuo","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B11","unstructured":"The R Project for Statistical Computing2023"},{"key":"B12","unstructured":"MatchIt: Nonparametric Preprocessing for Parametric Causal Inference\n            HoD\n            ImaiK\n            KingG\n            StuartE\n            WhitworthA\n            GreiferN\n          2023"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/bjs.9868","article-title":"Donor Characteristics and Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation","volume":"102","author":"Orci","year":"2015","journal-title":"Br J Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/lt.23902","article-title":"Time to Transplantation as a Predictor of Hepatocellular Carcinoma Recurrence after Liver Transplantation","volume":"20","author":"Samoylova","year":"2014","journal-title":"Liver Transpl"},{"key":"B15","unstructured":"Gtsummary: Presentation-Ready Data Summary and Analytic Result Tables\n            SjobergDD\n            LarmarangeJ\n            CurryM\n            LaveryJ\n            WhitingK\n            ZaborEC\n          2023"},{"key":"B16","unstructured":"Survminer: Drawing Survival Curves Using \u201cGgplot2\u201d\n            KassambaraA\n            KosinskiM\n            BiecekP\n            FabianS\n          2021"},{"key":"B17","unstructured":"TL (Original S >R Port and R Maintainer, Elizabeth A, Cynthia C. Survival: Survival Analysis)\n            TherneauTM\n          2009"},{"key":"B18","unstructured":"Tidycmprsk: Competing Risks Estimation\n            SjobergDD\n            FeiT\n          2023"},{"key":"B19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.trre.2018.10.004","article-title":"Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Liver Transplant: Current State and Future Directions","volume":"33","author":"Sellers","year":"2019","journal-title":"Transplant Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4254\/wjh.v9.i2.99","article-title":"Impact of Transjugular Intrahepatic Porto-Systemic Shunt on post Liver Transplantation Outcomes: Study Based on the United Network for Organ Sharing Database","volume":"9","author":"Mumtaz","year":"2017","journal-title":"World J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00423-023-02875-8","article-title":"Liver Transplantation and Hepatocellular Carcinoma: Is TIPS Deleterious? A Multicentric Retrospective Study of the ARCHET Research Group with Propensity Score Matching","volume":"408","author":"Laurent","year":"2023","journal-title":"Langenbecks Arch Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40644-022-00451-9","article-title":"TIPS Improves Outcomes in Patients with HCC and Symptomatic portal Hypertension: A Multi-Institution Experience","volume":"22","author":"Yan","year":"2022","journal-title":"Cancer Imaging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ueg2.12454","article-title":"Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma: A Systematic Review","volume":"11","author":"Norero","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.12998\/wjcc.v7.i13.1599","article-title":"Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt Combined with Palliative Treatment in Patients with Hepatocellular Carcinoma","volume":"7","author":"Luo","year":"2019","journal-title":"World J Clin Cases"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101790","DOI":"10.1016\/j.clinre.2021.101790","article-title":"TIPS for Patients with Early HCC: A Bridge to Liver Transplantation","volume":"46","author":"Larrey","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s12072-022-10388-7","article-title":"Prevention of Variceal Rebleeding in Cirrhotic Patients with Advanced Hepatocellular Carcinoma Receiving Molecularly Targeted Therapy: A Randomized Pilot Study of Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Plus \u03b2-Blocker","volume":"16","author":"Chen","year":"2022","journal-title":"Hepatol Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.hpb.2018.10.005","article-title":"Multicenter Validation of a Score to Predict Prognosis after the Development of HCC Recurrence Following Liver Transplantation","volume":"21","author":"Goldaracena","year":"2019","journal-title":"HPB"},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1724600821996372","article-title":"Changes in Hepatocellular Carcinoma Aggressiveness Characteristics with an Increase in Tumor Diameter","volume":"36","author":"Carr","year":"2021","journal-title":"Int J Biol Markers"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1053\/jhep.1996.v23.pm0008621125","article-title":"Relationship between Hepatocyte Proliferative Activity and Liver Functional reserve in Human Cirrhosis","volume":"23","author":"Delhaye","year":"1996","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7476477","DOI":"10.1155\/2022\/7476477","article-title":"The Relationship and Changes of Liver Blood Supply, Portal Pressure Gradient, and Liver Volume Following TIPS in Cirrhosis","volume":"2022","author":"He","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10535","DOI":"10.1038\/s41598-021-89764-6","article-title":"Hepatic Parenchyma and Vascular Blood Flow Changes after TIPS with Spectral CT Iodine Density in HBV-Related Liver Cirrhosis","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12781\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T07:54:42Z","timestamp":1720598082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12781\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":31,"alternative-id":["10.3389\/ti.2024.12781"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.12781","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"article-number":"12781"}}